University of Michigan

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).

1,327 total trials 179 currently recruiting 971 completed early-phase tilt top decile by trial count

University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.

University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.

Top-decile sponsor footprint

University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,327 total, page 23 of 27

TERMINATED

Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy

NCT01832831

COMPLETED NA

Study of Exercise Training in Hypertrophic Cardiomyopathy

NCT01127061

COMPLETED NA

Developing an Intervention to Address Suicide Risk During Substance Use Disorder

NCT01127932

COMPLETED Phase 1

Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation

NCT00980278

COMPLETED NA

A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral Sclerosis

NCT01119001

COMPLETED

Face of Sleepiness

NCT01060436

COMPLETED NA

Peer-Led Self-Management Support in "Real World" Clinical and Community Settings

NCT01517919

COMPLETED Phase 3

Tobacco Tactics Website for Operating Engineers

NCT01124110

COMPLETED NA

Quality of Life in Food Allergic Families

NCT01054950

COMPLETED NA

An In-home Study of Brain Computer Interfaces

NCT01123200

COMPLETED

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

NCT01071707

COMPLETED NA

Efficacy of Non Contrast DWI(Diffusion Weighted Imaging) Imaging Compared to DMR-DE

NCT01820000

COMPLETED NA

Heart Failure Patient Self-Management Web Portal Pilot Study

NCT01009151

COMPLETED

Premature Coronary Artery Disease (CAD) in Severe Psoriasis

NCT00893126

COMPLETED

F.Y.I.: Flint Youth Injury Study

NCT01152970

COMPLETED Phase 4

Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)

NCT01048879

COMPLETED NA

Brief Motivational Interviewing to Reduce Child Body Mass Index

NCT01335308

COMPLETED NA

Relationship of Motor Skill Competency and Physical Fitness to Physical Activity in Elementary School Students

NCT03015337

COMPLETED

Lung HIV Microbiome Project (Michigan Site)

NCT02392182

COMPLETED NA

Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients

NCT00734357

COMPLETED NA

Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites

NCT00747201

COMPLETED Phase 3

Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial

NCT00878644

COMPLETED NA

Mental Health First Aid for College Students

NCT02021344

COMPLETED NA

Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial

NCT00880087

TERMINATED Phase 2

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

NCT01042795

COMPLETED Phase 4

Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions

NCT00906087

COMPLETED NA

A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants

NCT01934530

COMPLETED NA

Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury

NCT01555567

TERMINATED NA

Impact of Volume Imaging Using Diagnostic Ultrasound

NCT01601782

COMPLETED

Retinol-induced Dermatitis in Aged Skin

NCT00857610

COMPLETED NA

Asthma Self-Management in Older Adults

NCT00941694

COMPLETED NA

Pedometers for Gestational Diabetes

NCT00862602

COMPLETED NA

Coronary Computed Tomography (CT) Angiography Versus Standard Therapy in the Emergency Room

NCT00846469

COMPLETED NA

Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet in Diastolic Heart Failure

NCT00939640

COMPLETED NA

Quantitative MR Biomarkers for Sarcoma Treatment

NCT01017978

COMPLETED NA

Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients

NCT00974025

COMPLETED NA

Health Benefits of Chronic vs. Acute Exercise in Overweight Adults

NCT01452087

COMPLETED

Development of Inflammatory Disease Model Protein, Genetic and Microbial Biomarkers

NCT00980525

COMPLETED NA

Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure

NCT01029691

COMPLETED NA

Tailored Web-Based Intervention for Cancer Patients and Family Caregivers

NCT01415089

COMPLETED NA

Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial

NCT00974636

COMPLETED NA

Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates

NCT00887393

COMPLETED NA

Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II

NCT02003469

COMPLETED Phase 2

Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression

NCT01545843

COMPLETED NA

Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound

NCT00859261

COMPLETED Phase 4

Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis

NCT00877370

COMPLETED

A Study of Mood and Stress After Spinal Cord Injury

NCT01337908

COMPLETED

Examining the Genetic Predictors of Coronary Artery Calcification in African Americans

NCT00925561

COMPLETED NA

Refinement and Assessment of New MRI Technologies for Thoracic/ Cardiovascular Exams

NCT00727792

COMPLETED NA

Exercise Dose Response for Improving Insulin Sensitivity

NCT01452035

← Previous Page 23 of 27 Next →

Phase Distribution

PhaseTrial count
Phase 1 79
Phase 2 80
Phase 3 25
Phase 4 69

What is open in the University of Michigan pipeline

179 recruiting of 1,327 indexed (13% open); 971 completed (73%).

Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).

Top condition: Depression (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Michigan: open-pipeline peers nationwide

Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share University of MichiganEli Lilly and CompanyGlaxoSmithKlineAstraZenecaUniversity of Colorado, DenverWayne State UniversityCase Comprehensive Cancer CenterAlbany Medical CollegeTaiho Oncology
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,327 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Michigan page

1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.

  • 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.